Literature DB >> 11358483

Gene transfer into neurons from hippocampal slices: comparison of recombinant Semliki Forest Virus, adenovirus, adeno-associated virus, lentivirus, and measles virus.

M U Ehrengruber1, S Hennou, H Büeler, H Y Naim, N Déglon, K Lundstrom.   

Abstract

Viral vectors are useful for transferring genes into neurons. Here, we characterized recombinant Semliki Forest virus (SFV), adenovirus type 5 (Ad5), adeno-associated virus type 2 (AAV), lentivirus, and measles virus (MV) by their expression of green fluorescent protein (GFP) in rat hippocampal slice cultures. SFV infected more neurons (>90% of all GFP-positive cells) than AAV, lentivirus, and MV (71, 69, and 62%, respectively), whereas no infected neurons were identified with Ad5. AAV-mediated GFP expression was neuron-specific when the platelet-derived growth factor beta-chain promoter rather than cytomegalovirus promoter was used. Transgene expression occurred rapidly but transiently for SFV, increased slowly but remained stable with AAV and lentivirus, and was fast with MV. Resting membrane potential and conductance, action potentials, firing accommodation, and H-current appeared normal in infected CA1 pyramidal cells. Thus, SFV is useful for short-term and AAV and lentivirus for long-term transduction of hippocampal slices, while MV constitutes a novel vector. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11358483     DOI: 10.1006/mcne.2001.0982

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  48 in total

1.  Safety aspects related to recombinant protein expression from Semliki Forest virus vectors.

Authors:  K Lundstrom; D Rotmann; D Hermann; E J Schlaeger
Journal:  Cytotechnology       Date:  2001-05       Impact factor: 2.058

2.  Corpus callosum: a favorable target for rSFV-mediated gene transfer to rat brain with broad and efficient expression.

Authors:  Zhao-Jian Li; Peng Sun; Hong-Di Zhang; Shi-Fang Li; Xia Liu; Ren-Zhi Wang
Journal:  J Mol Neurosci       Date:  2010-05-12       Impact factor: 3.444

3.  Involvement of protein synthesis and degradation in long-term potentiation of Schaffer collateral CA1 synapses.

Authors:  Anna Karpova; Marina Mikhaylova; Ulrich Thomas; Thomas Knöpfel; Thomas Behnisch
Journal:  J Neurosci       Date:  2006-05-03       Impact factor: 6.167

4.  Construction of cell-type specific promoter lentiviruses for optically guiding electrophysiological recordings and for targeted gene delivery.

Authors:  Aaron M Jasnow; Donald G Rainnie; Kimberly A Maguschak; Jasmeer P Chhatwal; Kerry J Ressler
Journal:  Methods Mol Biol       Date:  2009

5.  Mitochondrial imaging in dorsal root ganglion neurons following the application of inducible adenoviral vector expressing two fluorescent proteins.

Authors:  Payman Nasr; Patrick G Sullivan; George M Smith
Journal:  J Neurosci Methods       Date:  2008-05-03       Impact factor: 2.390

6.  Dual myxovirus screen identifies a small-molecule agonist of the host antiviral response.

Authors:  Dan Yan; Stefanie A Krumm; Aiming Sun; David A Steinhauer; Ming Luo; Martin L Moore; Richard K Plemper
Journal:  J Virol       Date:  2013-08-07       Impact factor: 5.103

Review 7.  Progress in transduction of cerebellar Purkinje cells in vivo using viral vectors.

Authors:  Hirokazu Hirai
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

Review 8.  Viral vectors for therapy of neurologic diseases.

Authors:  Sourav R Choudhury; Eloise Hudry; Casey A Maguire; Miguel Sena-Esteves; Xandra O Breakefield; Paola Grandi
Journal:  Neuropharmacology       Date:  2016-02-21       Impact factor: 5.250

9.  Nonnucleoside inhibitor of measles virus RNA-dependent RNA polymerase complex activity.

Authors:  Laura K White; Jeong-Joong Yoon; Jin K Lee; Aiming Sun; Yuhong Du; Haian Fu; James P Snyder; Richard K Plemper
Journal:  Antimicrob Agents Chemother       Date:  2007-04-30       Impact factor: 5.191

Review 10.  Measles virus.

Authors:  Hussein Y Naim
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.